ProBiotix Health Plc

Research ProBiotix Health Plc (PBX.AQ) on Bullrun: market cap GBP 1.35B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBP 1.35B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 2.73M-GBP 1.23M-GBP 379.00K54.2%n/aGBP 1.27Mn/aGBP 1.44M
FY2024GBP 1.88M-GBP 847.00K-GBP 1.07M52.9%n/aGBP 1.65Mn/aGBP 1.92M
FY2023GBP 1.67M-GBP 747.00K-GBP 238.00K52.1%-0.01GBP 1.50Mn/aGBP 1.53M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18GBP 1.35Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 GBP.

About ProBiotix Health Plc

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is ProBiotix Health Plc's market cap?

ProBiotix Health Plc's market capitalization is GBP 1.35B.

What does ProBiotix Health Plc do?

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022.